Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, together with its national and international collaborators, developed a new cell screening method that can be used to identify potential anti-influenza drugs.
The researchers were able to identify two novel compounds with anti-influenza activity, obatoclax and gemcitabine an
